American researchers discuss the mechanisms and applications of various gene-editing technologies for treating multiple inherited retinal diseases (IRDs). Technologies include adeno-associated virus vectors, lentiviruses, CRISPR/Cas9 systems, base and prime editing, antisense oligonucleotides, short-hairpin RNAs, Cas13, and adenosine deaminase acting on RNA. Also discussed are the various stages of clinical trials using these technologies and the impacts they have made in advancing the practice of medicine.
A review by Indian researchers looks into the usefulness of the CRISPR-Cas technology against various lung cancers. Particular emphasis is laid upon how to tackle drug-resistant lung cancers responsible for many cases of failure and relapse of lung cancer.
Jennifer Doudna is co-authoring a review about treating genetic diseases with CRISPR genome editing. The study discusses the basics of CRISPR, including DNA repair, indel formation, gene disruption, sequence insertions and the challenge of controlling the exact editing outcome.
Meetings and webinars
On Wednesday, 21 September, CRISPR Medicine News is hosting a webinar entitled "Gene Editing for Rare Skin Disorder Junctional Epidermolysis Bullosa" by Dr Johannes Bischof from University Hospital of the Paracelsus Medical University Salzburg, Austria. The webinar is free to attend, and you can sign up here. You can also read our recent interview with Dr Johannes Bischof.
The 1st edition of the CRISPR Screening in Cancer Discovery meeting will be held on Monday, 26 September 2022, at the Palais du Pharo in Marseille. You can still sign up to attend and even present a poster. Read the preliminary program and check out the conference's website to find out how to sign up.
Opinion and comments
Have you ever wondered how CRISPR could change dentistry? Then read this piece in Dental Hygiene that suggests using CRISPR to treat oral cancer, inhibit plaque formation, and reduction/prevention of dental caries and periodontal disease.